Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy for glioblastoma: the promise of combination strategies
Mathilde Bausart, Véronique Préat, Alessio Malfanti
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
Marianna Makowska, Beata Smolarz, Hanna Romanowicz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3521-3521
Open Access | Times Cited: 60
CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression
Andrew S. Luksik, Eli Yazigi, Pavan P. Shah, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1414-1414
Open Access | Times Cited: 49
Immunoadjuvant-Functionalized Metal-Organic Frameworks：Synthesis and Applications in Tumor Immune Modulation
Chen Zhao, Weihua Song, Jianing Wang, et al.
Chemical Communications (2024)
Closed Access | Times Cited: 34
Principles in the Management of Glioblastoma
Domingos Sanchez Roda, Pedro Veiga, Joana Barbosa Melo, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 501-501
Open Access | Times Cited: 17
Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements
Edoardo Agosti, Marco Zeppieri, Lucio De Maria, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15037-15037
Open Access | Times Cited: 38
Impact of age and gender on glioblastoma onset, progression, and management
Ambra Colopi, Serena Fuda, Samuele Santi, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111801-111801
Closed Access | Times Cited: 36
Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival
Giuseppina Catania, Giulia Rodella, Kévin Vanvarenberg, et al.
Biomaterials (2023) Vol. 294, pp. 122006-122006
Closed Access | Times Cited: 33
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 31
Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment
Nerea Iturrioz-Rodríguez, Nicolás Samprón, Ander Matheu
Theranostics (2023) Vol. 13, Iss. 9, pp. 2734-2756
Open Access | Times Cited: 29
Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma
Shaoping Jiang, Wenpei Li, Jun Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 8, pp. 6445-6462
Closed Access | Times Cited: 13
Targeted Glioma Therapy—Clinical Trials and Future Directions
A. B. Shikalov, Igor Koman, Natalya M. Kogan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review
Anup K. Ghosh, Aparajita Ghosh, Prasanta Kumar Das
ACS Applied Nano Materials (2024) Vol. 7, Iss. 3, pp. 2430-2460
Closed Access | Times Cited: 12
Aberrant MET Receptor Tyrosine Kinase Signaling in Glioblastoma: Targeted Therapy and Future Directions
Abdulhameed Al‐Ghabkari, Bruce Huang, Morag Park
Cells (2024) Vol. 13, Iss. 3, pp. 218-218
Open Access | Times Cited: 10
A systematic review of immunotherapy in high-grade glioma: learning from the past to shape future perspectives
Giacomo Sferruzza, Stefano Consoli, Fedele Dono, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2561-2578
Closed Access | Times Cited: 9
Recent advances in targeted drug delivery for the treatment of glioblastoma
Meng Mao, Yingjie Wu, Qiang He
Nanoscale (2024) Vol. 16, Iss. 18, pp. 8689-8707
Closed Access | Times Cited: 9
Tumor‐Associated Macrophages Nano‐Reprogrammers Induce “Gear Effect” to Empower Glioblastoma Immunotherapy
Yang Wang, Guangzhe Li, Jianlong Su, et al.
Small (2025)
Closed Access | Times Cited: 1
Immunity/metabolism dual-regulation via an acidity-triggered bioorthogonal assembly nanoplatform enhances glioblastoma immunotherapy by targeting CXCL12/CXCR4 and adenosine-A2AR pathways
Ruili Wei, Kunfeng Xie, Tao Li, et al.
Biomaterials (2025) Vol. 319, pp. 123216-123216
Closed Access | Times Cited: 1
LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF/USP7 axis
Yujie Zhou, Zhen Zhao, Jiang Cheng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Repurposing chemotherapeutics in a hyaluronic acid-conjugate combination treatment approach for the local immunomodulation of the glioblastoma microenvironment
Giulia Rodella, Zhanjun Ma, Bernard Učakar, et al.
International Journal of Pharmaceutics (2025), pp. 125612-125612
Open Access | Times Cited: 1
Carboxylated graphene quantum dots-mediated photothermal therapy enhances drug-membrane permeability, ROS production, and the immune system recruitment on 3D glioblastoma models
Giordano Perini, Valentina Palmieri, Ginevra Friggeri, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy
Jie Li, Huamin Zeng, Luwei Li, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24593-24618
Closed Access | Times Cited: 22
It comes from the sea: macroalgae-derived bioactive compounds with anti-cancer potential
Paulo Nova, Ana Gomes, Ana Rita Costa-Pinto
Critical Reviews in Biotechnology (2023) Vol. 44, Iss. 3, pp. 462-476
Open Access | Times Cited: 20
BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
CAR-NK cell therapy for glioblastoma: what to do next?
Qi Xiong, Jiao Zhu, Yong Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
From glioma gloom to immune bloom: unveiling novel immunotherapeutic paradigms-a review
Moksada Regmi, Yingjie Wang, Weihai Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top